Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 393 full-time employees. The company went IPO on 2005-08-01. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.